Thursday, July 24, 2025
LBNN
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • Documentaries
No Result
View All Result
LBNN

Evidence from adults seeking treatment reveals intriguing oligogenic patterns

Simon Osuji by Simon Osuji
August 14, 2023
in Artificial Intelligence
0
Evidence from adults seeking treatment reveals intriguing oligogenic patterns
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Obesity is a complex disorder that is dependent on environmental and genetic factors. Severe obesity, which is otherwise known as class III obesity, is a chronic condition that increases the risk of mortality and morbidity.

Current estimates indicate that the healthcare costs of individuals with severe obesity are 40% greater as compared to people with normal weight. Therefore, it is important to understand the etiology of class III obesity.

Study: Severe obesity may be an oligogenic condition: evidence from 1,714 adults seeking treatment in the UK National Health Service. Image Credit: Fuss Sergey / Shutterstock.com

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Background

Genetic research has revealed that several common genes have a subtle influence on body mass index (BMI) or increase the risk of obesity. Although a monogenic form of obesity has been identified, it is a rare occurrence in the general population; however, its frequency may be greater in a clinically obese cohort.

As compared to adults, a greater amount of research has been dedicated to understanding the complexities of severe forms of childhood obesity. As a result, limited precision medicine approaches have been developed to treat adults with class III obesity.

Although the effect of oligogenic inheritance has been established for many diseases, there is a lack of evidence regarding its influence on severe obesity.

About the study

A recent study posted to the medRxiv preprint server explores the prevalence of rare genetic forms of obesity in a United Kingdom-based clinical obesity cohort. A custom-designed rare-variant genotyping array was developed to determine genes related to Mendelian forms of obesity and diabetes. 

For this study, 27 genes that clinically indicate severe early-onset obesity were considered, in addition to 51 genes linked to syndromic and non-syndromic obesity. All genetic variants present in the Human Gene Mutation Database (HGMD) for each of the selected genes were selected, irrespective of their phenotypes or pathogenicity levels.

The newly developed genotyping array was applied to 1,714 unrelated adults seeking treatment for severe obesity. These participants were recruited between 2011 and 2021 for the Personalised Medicine for Morbid Obesity (PMMO) National Health Service (NHS)-registered portfolio trial. The results of the genetic screen were compared with the clinical cohort containing 50,000 whole exome sequencing (WES) datasets from the U.K. Biobank.

Study findings

An optimized algorithm was used to determine the prevalence of genetic variants that potentially cause Mendelian forms of obesity in the U.K.-based obesity cohort. Notably, one in every twelve PMMO participants had rare variants in genes that clinically indicated severe childhood obesity. This estimation increased to one in four participants when gene variants were included.

Since severe adult obesity is a relatively unexplored area of research, standard clinical genetic measures could not be employed to “prune” mutations for inclusion criteria. About 10% of the included genetic variants were classified as variants of uncertain significance (VUS).

As compared to previous studies, the current study observed a higher prevalence of possible Mendelian obesity. This disparity in results could be due to other studies considering variants from fewer genes.

When variants assigned to genes from an NHS panel used for clinical indication of severe early-onset obesity were considered, the current study estimates of 8.6% resembled findings documented in previous studies. 

Consistent with previous findings, the current study estimated that 0.88% of PMMO participants carried at least one rare variant in the MC4R gene. In the PMMO cohort, two participants carried both the MYT1L and GHSR genes. Future research must explore whether these two genes interact with each other to influence obesity risk.

The findings of the custom-designed rare-variant genotyping array were compared with the WES dataset of the UKB cohort, which revealed that the overall prevalence of qualifying variants was not significantly different. This finding was surprising, as the UKB cohort represented healthy individuals. 

Strengths and limitations

One of the key strengths of this study was the utilization of PMMO, which is based on an extreme phenotype of class III obesity. As a result, the frequency of rare genetic variants linked to severe obesity that cause Mendelian forms of obesity could be accurately determined. 

Although the newly developed genotyping methodology is cost-effective and time-efficient, it is associated with some limitations. For example, this approach cannot identify any novel variants linked to class III obesity, as it can only analyze variants present in the Genome Aggregation Database (gnomAD) or HGMD. Due to limited research in this field, the pathogenicity of many variants included in the array is not fully understood. 

Conclusions

PMMO participants with a putatively Mendelian form of obesity were more likely to carry predicted-deleterious mutations in more than one gene than U.K. Biobank participants. The study findings emphasize the role of oligogenic inheritance in severe obesity and the importance of genotyping arrays for rare variant screening.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.



Source link

Related posts

The Very Real Case for Brain-Computer Implants

The Very Real Case for Brain-Computer Implants

July 24, 2025
Automated tool detects silent errors in deep learning training

Automated tool detects silent errors in deep learning training

July 24, 2025
Previous Post

Kenyan-born Sophie Davarich shares US military accomplishment

Next Post

6 Strategies for Living with Gout | Gout Lifestyle Tips

Next Post
6 Strategies for Living with Gout | Gout Lifestyle Tips

6 Strategies for Living with Gout | Gout Lifestyle Tips

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

R2m to address eThekwini water challenges

R2m to address eThekwini water challenges

4 months ago
Salmon Introduces Auto-Debit for Seamless and Convenient Payments

Salmon Introduces Auto-Debit for Seamless and Convenient Payments

1 year ago
Cape Town’s new premium apartments with unmatched city views

Cape Town’s new premium apartments with unmatched city views

2 months ago
Ghana cocoa farmers restrict product supply amid price hike speculation

Ghana cocoa farmers restrict product supply amid price hike speculation

9 months ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0
  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0
  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0
  • Tanzania’s natural gas sector goes global with Dubai deal

    0 shares
    Share 0 Tweet 0
  • Privacy Policy
  • Contact

© 2023 LBNN - All rights reserved.

No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • Documentaries
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist

© 2023 LBNN - All rights reserved.